These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 9426463)
1. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent. Armstrong DJ; Roman A Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463 [TBL] [Abstract][Full Text] [Related]
2. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816 [TBL] [Abstract][Full Text] [Related]
3. Functional studies of E7 proteins from different HPV types. Ciccolini F; Di Pasquale G; Carlotti F; Crawford L; Tommasino M Oncogene; 1994 Sep; 9(9):2633-8. PubMed ID: 8058327 [TBL] [Abstract][Full Text] [Related]
4. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells. Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091 [TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation. Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185 [TBL] [Abstract][Full Text] [Related]
6. E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently. Hiraiwa A; Kiyono T; Suzuki S; Ohashi M; Ishibashi M Virus Genes; 1996; 12(1):27-35. PubMed ID: 8879118 [TBL] [Abstract][Full Text] [Related]
7. E2F-independent transcriptional repression by p107, a member of the retinoblastoma family of proteins. Dagnino L; Zhu L; Skorecki KL; Moses HL Cell Growth Differ; 1995 Feb; 6(2):191-8. PubMed ID: 7756178 [TBL] [Abstract][Full Text] [Related]
8. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1. Alevizopoulos K; Sanchez B; Amati B Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468 [TBL] [Abstract][Full Text] [Related]
10. Characterization of an E2F-p130 complex formed during growth arrest. Corbeil HB; Branton PE Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406 [TBL] [Abstract][Full Text] [Related]
11. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Bennett JD; Farlie PG; Watson RJ Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697 [TBL] [Abstract][Full Text] [Related]
12. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. O'Connor RJ; Schaley JE; Feeney G; Hearing P Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936 [TBL] [Abstract][Full Text] [Related]
13. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells. Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha. Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression. Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of transformation by the human papillomaviruses. Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182 [TBL] [Abstract][Full Text] [Related]
17. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter. Murvai M; Borbély AA; Kónya J; Gergely L; Veress G Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells. Hu X; Cress WD; Zhong Q; Zuckerman KS Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571 [TBL] [Abstract][Full Text] [Related]
19. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation. Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176 [TBL] [Abstract][Full Text] [Related]
20. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor. Hilton MJ; Mounghane D; McLean T; Contractor NV; O'Neil J; Carpenter K; Bachenheimer SL Virology; 1995 Nov; 213(2):624-38. PubMed ID: 7491786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]